Neoadjuvant Chemo Did Not Improve Disease-Free Survival - Quiz - MDSpire

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches

  • By

  • Andrea Surnit

  • May 1, 2026

  • 5 min

Share

Original Source(s)

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

  • by Andrea Surnit

  • May 1, 2026

Related Content

MRI May Improve Prostate Cancer Monitoring

Volume tracking and longitudinal imaging may enhance assessment of progression during active surveillance.

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Comparison of β-Lactam and Non–β-Lactam Antibiotic Prophylaxis in Elective Colorectal Surgical Procedures